News | Radiation Therapy | August 04, 2016

CIVCO Highlights Comprehensive Motion Management Solutions for Radiation Oncology at AAPM 2016

universal couchtop

CIVCO Medical Solutions, a provider of comprehensive motion management solutions for radiation oncology, exhibited its latest innovations and product offering to attendees of the American Association of Physicists in Medicine (AAPM) 58th Annual Meeting in Washington, D.C., in July.

The Universal Couchtop Long Extension (UCT LE) provides seamless imaging and treatment planning with dosimetrically matched couchtops that feature a large, junction-free and artifact-free treatment area. CIVCO's Body Pro-Lok SBRT bridges attach directly to the unique profile of the couchtop, enabling a seamlessly integrated SBRT immobilization platform. Seven additional extension options are available for treating many other disease sites.

The innovative C-Qual M Breastboard is indexable for efficient, accurate setups and features an enhanced bottom stop that comfortably supports the patient. The new Monarch Overhead Arm Positioner is designed to match body contours for optimal arm support and includes dual function hand grips allowing for enhanced wrist comfort and increased positioning options. These new innovations are made from image-friendly materials that are compatible with multiple treatment imaging modalities.

The Body Pro-Lok ONE SBRT Immobilization System allows for customized setups for varying patient sizes utilizing only one bridge. This advanced bridge design features variable height adjustment, and lateral and tilting offset capabilities that enable the bridge and plate to adapt to the patient's natural posture and body type. The bridge secures directly to the Universal Couchtop, eliminating the need for overlays and ensuring equivalent setups between CT and treatment.

For more information:

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...